Crafting a genomics strategy early is key for successful oncology drug development
An historic shift towards treating cancer based on a tumor’s genetics rather than its site of origin is underway. Genomically-targeted drugs, properly developed, have an inherent advantage over drugs that are not. But the success of any one will depend on good strategic planning, done early. Read about three key considerations for crafting a successful genomic biomarker strategy.
Related Insights
Blog
The Next Frontier of ADC Development: Navigating an Evolving Regulatory Landscape
Aug 12, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Blog
FDA novel oncology drug approvals in 2025: Trends and strategic insights for developers
Mar 31, 2026
Playbook
Advancing radiopharmaceutical development: A playbook for integrated clinical trial delivery
Mar 11, 2026
Playbook
Preparing clinical infrastructure for radiopharmaceutical trials
Mar 11, 2026
Playbook
Designing clinical development programs for radiopharmaceutical therapies
Mar 11, 2026
Playbook
Radiopharmaceuticals are transforming precision oncology
Mar 11, 2026
Playbook
Advancing radiopharmaceutical development: Integrated clinical trial expertise mitigates risk
Dec 3, 2025
Blog
Tightening rules, global trials: Sponsors’ concerns at ESMO 2025
Oct 27, 2025
Blog
Do we still need broad patient representation in breast cancer trials? Absolutely.
Oct 17, 2025
Webinar
Accelerating delivery of radiopharmaceutical trials
Oct 3, 2025
Related Insights
Blog
The Next Frontier of ADC Development: Navigating an Evolving Regulatory Landscape
Aug 12, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Blog
FDA novel oncology drug approvals in 2025: Trends and strategic insights for developers
Mar 31, 2026
Playbook
Advancing radiopharmaceutical development: A playbook for integrated clinical trial delivery
Mar 11, 2026
Playbook
Preparing clinical infrastructure for radiopharmaceutical trials
Mar 11, 2026
Playbook
Designing clinical development programs for radiopharmaceutical therapies
Mar 11, 2026
Playbook
Radiopharmaceuticals are transforming precision oncology
Mar 11, 2026
Playbook
Advancing radiopharmaceutical development: Integrated clinical trial expertise mitigates risk
Dec 3, 2025
Blog
Tightening rules, global trials: Sponsors’ concerns at ESMO 2025
Oct 27, 2025
Blog
Do we still need broad patient representation in breast cancer trials? Absolutely.
Oct 17, 2025
Webinar
Accelerating delivery of radiopharmaceutical trials
Oct 3, 2025